PAI-1
Original Article Meta-analysis of the association between endometriosis and polymorphisms in ACE and PAI-1
13
Lipoatrophy of the footpad in HIV-treated patients is associated with increased PAI-1
29
Elevated Tumor Expression of PAI 1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis
9
Erratum to Hypoxia induced down regulation of microRNA 449a/b impairs control over targeted SERPINE1 (PAI 1) mRNA a mechanism involved in SERPINE1 (PAI 1) overexpression
5
Glioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells
15
Significant associations of PAI 1 genetic polymorphisms with osteonecrosis of the femoral head
7
Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
7
synergistically increase PAI-1 expression in hepatic stellate cells of rats
9
"Hypoxia induced down regulation of microRNA 449a/b impairs control over targeted SERPINE1 (PAI 1) mRNA a mechanism involved in SERPINE1 (PAI 1) overexpression"
14
Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
12
The cellular microenvironment modulates the role of PAI 1 and vitronectin in mediating cell matrix interactions
19
A small molecule inhibitor of PAI-1 protects against doxorubicin- induced cellular senescence
15
Angiotensin induction of PAI 1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV
7
uPA and PAI 1 as biomarkers in breast cancer: validated for clinical use in level of evidence 1 studies
10
Overexpression of Rab11-FIP2 in colorectal cancer cells promotes tumor migration and angiogenesis through increasing secretion of PAI-1
13
High Concentrations of Plasminogen Activator Inhibitor-1 in Lungs of Preterm Infants With Respiratory Distress Syndrome
11
Plasminogen activator inhibitor 1 gene deficient mice II Effects on hemostasis, thrombosis, and thrombolysis
6
Expression of deleted in liver cancer 1 and plasminogen activator inhibitor 1 protein in ovarian carcinoma and their clinical significance
8
Combination of Thrombophilic Gene Polymorphisms as a Cause of Increased the Risk of Recurrent Pregnancy Loss
6
Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin
11